Psoriatic arthritis: new US guidelines put biologics first-line

Guidance also given on patients with comorbidities

For the first time, US guidelines are recommending treatment-naive patients with psoriatic arthritis be prescribed a tumour necrosis factor alpha (TNF-alpha) inhibitor as first-line treatment.